Order Article Reprints

Sciannameo V, Fadini GP, Bottigliengo D, Avogaro A, Baldi I, Gregori D, Berchialla P. Assessment of Glucose Lowering Medications’ Effectiveness for Cardiovascular Clinical Risk Management of Real-World Patients with Type 2 Diabetes: Targeted Maximum Likelihood Estimation under Model Misspecification and Missing Outcomes. International Journal of Environmental Research and Public Health. 2022; 19(22):14825. https://doi.org/10.3390/ijerph192214825

Sciannameo, Veronica, Gian Paolo Fadini, Daniele Bottigliengo, Angelo Avogaro, Ileana Baldi, Dario Gregori, and Paola Berchialla. 2022. "Assessment of Glucose Lowering Medications’ Effectiveness for Cardiovascular Clinical Risk Management of Real-World Patients with Type 2 Diabetes: Targeted Maximum Likelihood Estimation under Model Misspecification and Missing Outcomes" International Journal of Environmental Research and Public Health 19, no. 22: 14825. https://doi.org/10.3390/ijerph192214825

Sciannameo, V., Fadini, G. P., Bottigliengo, D., Avogaro, A., Baldi, I., Gregori, D., & Berchialla, P. (2022). Assessment of Glucose Lowering Medications’ Effectiveness for Cardiovascular Clinical Risk Management of Real-World Patients with Type 2 Diabetes: Targeted Maximum Likelihood Estimation under Model Misspecification and Missing Outcomes. International Journal of Environmental Research and Public Health, 19(22), 14825. https://doi.org/10.3390/ijerph192214825